News archive

Filter by: Reset

October 2019

- October 17, 2019
- Crown Bioscience
Patient-Derived Tumor Organoid Drug Development Platform Launched

Industry Leading Innovation Promises to Disrupt Traditional Drug Discovery

- May 9, 2019
- Crown Bioscience
Crown Bioscience Announces San Diego, CA Site Expansion

International Center of Excellence for oncology biomarker and inflammation translational services created

- March 26, 2019
- Crown Bioscience
CrownBio and Hubrecht Organoid Technology Announce a Strategic Partnership, including Exclusive License to Provide On...

Partnership combines breakthrough organoid technology with the world’s largest PDX collection to create a unique patient-derived translational research platform
- March 12, 2019
- Crown Bioscience
Crown Bioscience Inc. and Charles River Laboratories Enter Agreement to Expand Access to ZDSD Rat Model

Agreement enables greater global model availability for drug discovery in Obesity,  Diabetes and Metabolic Syndrome
- March 5, 2019
- Crown Bioscience
Crown Bioscience and The Jackson Laboratory Collaboration Enables Global Access to FATZO Mouse Model

Continued Collaboration Facilitates Global Distribution of Obesity, Metabolic Disease, and NASH Model and Priority Supply to CrownBio’s World-Class Cardiovascular, Obesity, and Metabolic Disease Pl...

- November 15, 2018
- Crown Bioscience
New Pancreatic Ductal Adenocarcinoma Research Published in Journal of Visualized Experiments

Paper describes well-established protocols for PDAC orthotopic tumor homograft model development and immunoprofiling
- November 8, 2018
- Crown Bioscience
Crown Bioscience Expands Cardiovascular & Metabolic Disease Research Capability

The Company Offers New Non-GLP Services & Translational Rodent Models at its expanded site in Louisiana

- October 25, 2018
- Crown Bioscience
CrownBio Releases MuBase® 2.0. An Open Access Database of Immuno-Oncology Murine Models

Updates enhance user experience, provide comprehensive characterization data, and add new models

- September 26, 2018
- Crown Bioscience
CrownBio Completes Validation of Prostate Cancer Patient-Derived Xenograft (PDX) Models

Unique well-characterized prostate models derived from castration resistant and hormone sensitive primary tissue now available for studies
- September 18, 2018
- Crown Bioscience
CrownBio Licenses Translational Breast Cancer Models of Resistance and Metastasis

CrownBio will market a set of new, highly characterized breast cancer models alongside their industry leading collection of more than 2500 PDX models (HuPrime®).
- September 10, 2018
- Crown Bioscience
CARsgen Therapeutics and CrownBio Complete CAR-T Study for Gastric Cancer

Claudin18.2 specific CAR-T cells show tumor elimination in PDX models

5 of 11